Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult Volunteers.
Yendewa GA, Griffiss JM, Gray WA, Healen A, Proskin HM, Fulton SA, O'Riordan MA, Hoppel C, Blumer JL, Salata RA. Yendewa GA, et al. Among authors: proskin hm. Antibiotics (Basel). 2022 Apr 6;11(4):490. doi: 10.3390/antibiotics11040490. Antibiotics (Basel). 2022. PMID: 35453240 Free PMC article.
Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.
Healan AM, Griffiss JM, Proskin HM, O'Riordan MA, Gray WA, Salata RA, Blumer JL. Healan AM, et al. Among authors: proskin hm. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e00855-17. doi: 10.1128/AAC.00855-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29061739 Free PMC article. Clinical Trial.
A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation.
Yendewa GA, Griffiss JM, Jacobs MR, Fulton SA, O'Riordan MA, Gray WA, Proskin HM, Winkle P, Salata RA. Yendewa GA, et al. Among authors: proskin hm. J Glob Antimicrob Resist. 2020 Jun;21:171-180. doi: 10.1016/j.jgar.2019.09.017. Epub 2019 Oct 7. J Glob Antimicrob Resist. 2020. PMID: 31600598 Free PMC article. Clinical Trial.
Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6.
DeCory HH, Sanfilippo CM, Proskin HM, Blondeau JM. DeCory HH, et al. Among authors: proskin hm. PLoS One. 2020 Aug 25;15(8):e0237603. doi: 10.1371/journal.pone.0237603. eCollection 2020. PLoS One. 2020. PMID: 32841261 Free PMC article. Clinical Trial.
Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.
Carlson AP, Hänggi D, Wong GK, Etminan N, Mayer SA, Aldrich F, Diringer MN, Schmutzhard E, Faleck HJ, Ng D, Saville BR, Bleck T, Grubb R Jr, Miller M, Suarez JI, Proskin HM, Macdonald RL; NEWTON Investigators. Carlson AP, et al. Among authors: proskin hm. Stroke. 2020 Apr;51(4):1142-1149. doi: 10.1161/STROKEAHA.119.027396. Epub 2020 Mar 6. Stroke. 2020. PMID: 32138631 Clinical Trial.
169 results